CYTK
Cytokinetics Inc
65.60$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +29.5% | -28.9% | +11.9% | +103.7% | -28.6% | +85.3% | -8.3% | -43.7% | +40.2% | -36.4% | -32.3% | +47.0% | +7.3% | +59.8% | -13.3% | +47.6% | +73.3% | -28.4% | +37.2% | +84.2% | +57.6% | +20.6% | -18.8% | +70.0% | +1.6% | |
| – | – | – | +32.7% | +194.2% | -27.7% | +94.8% | -20.6% | -51.7% | +98.5% | -37.1% | -30.4% | +49.4% | +3.8% | +65.3% | -13.7% | +40.3% | +72.9% | -24.3% | +12.6% | +102.9% | +13.0% | +48.4% | -21.0% | +76.4% | -17.2% | |
| – | – | – | -32.9% | +18.8% | +3.5% | +191.4% | +195.9% | -64.1% | -38.9% | -31.5% | +7.5% | -20.8% | +35.2% | +0.3% | +221.9% | +2.8% | +87.2% | -66.3% | -13.8% | +127.8% | +35.8% | -41.8% | +72.3% | -16.1% | +29.2% | |
| – | – | – | +31.2% | +200.4% | -27.9% | +43.7% | +9.3% | -52.5% | +101.7% | -37.6% | -31.6% | +50.9% | +5.0% | +7.1% | +33.9% | +40.2% | +72.1% | -26.1% | +13.3% | +106.1% | +1.6% | +65.9% | -21.4% | +75.0% | -18.0% | |
| – | – | – | +1,543.8% | +191.3% | -5.1% | +5,708.9% | -99.5% | +22.0% | -27.6% | -75.7% | -69.6% | -71.4% | +25.0% | +932,820.0% | -100.0% | +100.0% | +4,533.3% | +510.2% | -23.9% | -14.4% | +1,072.4% | -99.7% | +772.8% | +1,197.7% | +6.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -100.0% | – | – | -678,500,100.0% | – | – | – | – | – | – | – | |
| – | – | – | -9.0% | -17.3% | -15.8% | +48.9% | -16.0% | -34.2% | -27.0% | -37.5% | -43.6% | -23.9% | +22.5% | +34.1% | +7.0% | +107.7% | -1.9% | -10.2% | +41.4% | +194.6% | +449.0% | +9.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +40.4% | +0.3% | +32.7% | -86.7% | -12.9% | +253.1% | -12.3% | -32.0% | -43.8% | -64.7% | -38.5% | +33.0% | +370.4% | +42.3% | +14.0% | +62.5% | +144.1% | +0.1% | +62.4% | +39.8% | +42.1% | +87.9% | +7.8% | +27.0% | +35.6% | |
| – | – | – | +0.9% | +16.7% | +2.0% | +134.3% | +0.2% | -13.5% | -11.8% | -63.7% | -37.3% | +25.2% | +364.4% | -10.7% | +32.7% | +5.1% | -2.4% | -31.6% | +17.3% | +19.9% | +130.3% | +17.8% | +21.3% | +75.0% | +12.7% | |
| – | – | – | -16.9% | +18.9% | +14.2% | +35.4% | +9.8% | -50.0% | -20.2% | -48.5% | -81.8% | +791.4% | +173.7% | -63.3% | +64.4% | +11.7% | +110.1% | -50.4% | +77.1% | -39.7% | +433.7% | -7.2% | +102.9% | +9.0% | +97.7% | |
| – | – | – | -1.2% | +29.6% | +14.2% | +20.7% | -44.2% | -12.8% | +21.8% | -33.5% | +8.0% | +78.1% | +72.4% | -63.3% | +64.4% | +89.3% | +24.0% | -28.3% | +116.8% | -1.3% | +162.0% | +21.5% | -16.0% | -5.3% | +9.7% | |
| – | – | – | +14.1% | +0.4% | -18.1% | +7.7% | -35.1% | -43.6% | -62.3% | -84.6% | -100.0% | – | – | – | – | +87.0% | +16.1% | +25.3% | +13.2% | +2.6% | +2.5% | +34.7% | +851.8% | +6.3% | +72.9% | |
| – | – | – | – | – | -31.6% | +44.5% | -6.0% | -50.2% | +103.8% | -30.5% | -31.7% | +48.3% | -23.8% | +69.1% | -25.5% | +37.6% | +16.4% | -76.4% | -142.2% | – | +115.1% | -144.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +47.1% | +22.7% | +9.7% | +934.8% | +44.5% | +28.1% | +30.0% | +3.8% | +17.3% | +10.7% | +10.3% | +53.4% | +50.6% | +30.9% | +8.7% | +9.7% | +16.1% | +10.2% | +5.8% | +12.1% | +19.2% | +16.8% | +7.5% | +16.0% | +7.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.